Today: 13 June 2026
Browse Category

NASDAQ:ATRA 12 January 2026 - 9 March 2026

Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus

Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus

Atara Biotherapeutics shares jumped 18% Monday after reports that FDA biologics chief Vinay Prasad will depart in April. The move follows the agency’s January rejection of Atara’s EBVALLO therapy for a rare blood cancer, which wiped out 56% of the stock’s value. Atara and partner Pierre Fabre have requested a Type A meeting with the FDA to revisit the decision. Atara ended 2025 with $8.5 million in cash.
9 March 2026
····
Atara Biotherapeutics stock dives on FDA EBVALLO rejection — what ATRA investors watch next

Atara Biotherapeutics stock dives on FDA EBVALLO rejection — what ATRA investors watch next

Atara Biotherapeutics shares fell 56% after the FDA rejected its cell therapy EBVALLO for a rare post-transplant cancer, citing insufficient evidence from the single-arm ALLELE study. The agency said previous manufacturing issues were resolved but requested new efficacy data. Atara and partner Pierre Fabre plan expedited talks with the FDA. The company reported $8.5 million in cash at year-end.
12 January 2026
··

Stock Market Today

  • Silicon Valley IPO Boom Widens Wealth Gap Among Tech Workers
    June 13, 2026, 8:44 AM EDT. The surge in initial public offerings (IPOs) from high-profile firms such as SpaceX, Anthropic, and OpenAI is reshaping wealth distribution in Silicon Valley. These listings have created new millionaires and billionaires, boosting fortunes at the top. However, not all tech workers benefit equally. While some employees gain significant wealth from stock options and shares during these IPOs, others face uncertainty and slower financial growth. This divide highlights the growing economic disparity within the tech sector as rapid valuations lift a select few, leaving many concerned about their financial futures amid the boom.

Latest articles

Oil stocks set for weekend as crude drops on Iran deal talk

Oil stocks set for weekend as crude drops on Iran deal talk

13 June 2026
Brent crude plunged 3.37% to $87.33 and WTI fell 3.23% to $84.88 Friday as hopes for a U.S.-Iran deal slashed oil’s geopolitical risk premium, but energy stocks like XLE closed nearly flat for the week, with investors awaiting confirmation of a memorandum and real oil flow changes through the Strait of Hormuz before making their next move.
AMD Upgrade, SK Hynix Nasdaq Plan Push AI Chip Makers Higher

AMD Upgrade, SK Hynix Nasdaq Plan Push AI Chip Makers Higher

13 June 2026
AMD soared 4.7% to $511.57 after Citi upgraded the stock to Buy and raised its price target to $575, citing AMD’s growing strength in AI GPUs and potential deals with Meta, while Nvidia was little changed and Broadcom slipped despite record AI revenue.
Big Tech Trades Lower With SpaceX IPO and Fed In Focus

Big Tech Trades Lower With SpaceX IPO and Fed In Focus

13 June 2026
Hedge funds dumped major tech stocks ahead of SpaceX’s record IPO, dragging the Magnificent Seven ETF down over 2.4% since June 5 even as the Nasdaq rose, as investors brace for the Fed’s June 16–17 meeting and updated rate projections.
Go toTop